2026 Bundibugyo Ebola Outbreak: Cases, No Approved Treatments, and Africa’s Push for Health Sovereignty

No Approved Vaccines or Treatments for the Bundibugyo Strain

Unlike the Zaire ebolavirus (for which licensed vaccines and monoclonal antibody therapies exist), there are no authorized vaccines or specific treatments for the Bundibugyo virus . The European Medicines Agency (EMA) confirmed that no vaccines or treatments are authorized for Bundibugyo virus disease . Imperial College London noted that existing licensed monoclonal antibody therapeutics are specific to the Zaire strain, leaving only supportive care (rehydration, electrolyte management) as the treatment option . On May 28, WHO expert advisory groups recommended that any candidate vaccines or therapeutics be used exclusively within clinical trials . Africa CDC's Director-General has stated that a Bundibugyo-specific vaccine is targeted for readiness by the end of 2026 .

Ramaphosa's Call for African Health Self-Reliance

On June 16, 2026, South African President Cyril Ramaphosa — in his capacity as the AU Champion on Pandemic Prevention, Preparedness and Response — addressed a high-level virtual meeting of African heads of state on the Ebola outbreak . He emphasized that Africa cannot continue relying on remote supply chains and foreign goodwill during health emergencies, and must build its own capacity to produce and distribute essential medicines and vaccines . His government has framed this as a push for African "health sovereignty," including domestic vaccine and pharmaceutical manufacturing .

The $518 Million AU Response Plan

On June 5, 2026, Africa CDC and WHO jointly launched the Continental Preparedness and Response Plan for the outbreak, seeking $518 million to support African countries in detecting, containing, and responding to the epidemic . The six-month plan (June–November 2026) uses a "One Response" strategy to strengthen surveillance, laboratories, treatment, and cross-border coordination .

South Africa's $13.5 Million Pledge to Africa CDC

At the June 16 high-level meeting, President Ramaphosa announced that South Africa would increase its contribution, pledging $13.5 million to the Africa CDC to support treatment and containment of the outbreak . An earlier cabinet statement had referenced a $5 million contribution to a separate $319 million plan, but Ramaphosa's June 16 pledge of $13.5 million is the larger, more specific figure given at the head-of-state summit .

Nearly $38 Million in Additional U.S. Funding

Insufficient evidence. The search results available do not contain a confirmed, sourceable figure for "nearly $38 million in additional U.S. funding" for this specific outbreak. The CDC has mobilized response activities , and the U.S. government is actively engaged, but no specific dollar amount of new U.S. funding for the 2026 Bundibugyo response was found in the sourced material reviewed. This figure could not be independently verified from the available government or agency reports.